Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinomaTejas Jammihal, Sachet A. Shukla, Yasmin Nabil Laimon et al.|Nature Cancer|2025Cited by 32
1891P Determinants of exceptional response to immune checkpoint inhibition in metastatic clear cell renal cell carcinomaR.M. Saliby, D.A. Braun, Tejas Jammihal et al.|Annals of Oncology|2023Cited by 1
Metabolic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma.Renée Maria Saliby, David A. Braun, Chris Labaki et al.|Journal of Clinical Oncology|2025Cited by 1
ASXL1 Truncating Mutations Drive Leukemic Resistance to T Cell AttackDustin McCurry, Pavan Bachireddy, Zhongqi Ge et al.|Blood|2023Cited by 0
<i>ASXL1</i> truncating mutations drive leukemic resistance to T cell attackDustin McCurry, Pavan Bachireddy, Zhongqi Ge et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0